Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation

Pacemaker DDD Clinical Trial

Official title:

Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04957771
• Other study ID #: LM2019185
• Status: Completed
• Phase: N/A
• Start date: August 1, 2019
• Est. completion date: July 31, 2020

Study information

• Verified date: August 2019
• Source: Peking University Third Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to observe the changes of cardiopulmonary endurance in patients with pacemaker implantation after long-term exercise, to explore the significance of exercise on patients with pacemaker implantation, and to analyze the difference of the effect of exercise on cardiopulmonary endurance in patients with normal LVEF of different pacing ratios

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: July 31, 2020
• Est. primary completion date: July 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• 18-75 years old patients with pacemaker implantation for the first time,

• 3-6 months after operation

• stable condition,

• independent walking ability.

Exclusion Criteria:

• Cognitive impairment;

• ICD, CRT / Crtd implanted,

• patients with neurogenic syncope;

• Atrial tachycardia, atrial fibrillation,

• NYHA class II or above,

• difficult to control hypertension;

• Musculoskeletal disease limiting activity

• nervous system disease,

• severe respiratory disease,

• Patients with acute inflammation,

• cancer and other diseases uncontrolled.

Related Conditions & MeSH terms

• Pacemaker DDD

Intervention

Other:
• Supervise and guide regular exercise
Aerobic exercise, evaluated by cardiopulmonary exercise test, 3-5 times a week

Locations

Country	Name	City	State
China	Peking University Third Hospital	Beijing	Haidian

Sponsors (1)

Lead Sponsor	Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Parameters related to exercise cardiopulmonary assessment	VO2peak	followed up for one year